Visible Alpha provides a data and analytics platform that extracts granular forecasts and assumptions from sell-side analyst models to create transparent consensus data for investment research. This platform enables buy-side analysts to access comprehensive historical and forecast data, saving them an average of 13 hours per month while enhancing their ability to identify market opportunities.
Funding
Funding not disclosed
Founders
Product
Problem
Buy-side investment analysts often struggle to efficiently extract granular forecasts and assumptions from numerous sell-side analyst models. This process is time-consuming and makes it difficult to create a transparent consensus view of company performance.
Solution
Visible Alpha provides a platform that aggregates and extracts detailed forecasts, assumptions, and logic directly from sell-side analyst models. The platform creates a transparent consensus dataset, offering buy-side analysts comprehensive historical and forecast data. This allows users to access analyst data, company data, and industry data, including segment-level details, key drivers, and year-over-year growth. The platform aims to enhance investment research by providing more in-depth consensus data with higher quality sources and longer-term forecast horizons.
Target Audience
The primary users are hedge funds, asset managers, corporations, investment banks, equity research departments, quantitative funds, independent research providers, private equity firms, wealth managers, family offices, academia, and media outlets.
Features
- Extracts forecasts, assumptions, and logic from sell-side models to create granular consensus data.
- Provides access to analyst data, company data, and industry data.
- Offers historical data (VA Actuals) not typically found in filings.
- Includes tools for model downloads, Excel export, and formula auditing.
- Delivers data through a web application, Excel add-in, API, data feeds, and cloud delivery via Snowflake.
- Offers a customizable web interface with alerts and data visualizations.
- Provides access to consensus data on over 7,000 companies.
- Includes Visible Alpha BioPharma, which combines drug metadata with financial information.